California Public Employees Retirement System
CARM

California Public Employees Retirement System’s Carisma Therapeutics CARM Stock Holding History

California Public Employees Retirement System’s Portfolio CARM Stock Details CARM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-12,568
Closed -$654K – 1773
2021
Q1 		$654K Hold
12,568
– – ﹤0.01% 2793
2020
Q4 		$339K Buy
+12,568
New +$319K ﹤0.01% 3138

Other funds holding CARM

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TG
TRV GP Boston, Massachusetts $18.9M AUM 541.67% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

California Public Employees Retirement System's CARM Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Carisma Therapeutics (CARM) in Q2 2021, closing a stake of 12,568 shares — an estimated $654K sold.

California Public Employees Retirement System first reported a position in CARM in Q4 2020 and held it in 2 quarters. The position peaked at $654K in Q1 2021. 105 funds tracked by Wall St. Rank hold CARM as of Q2 2021.

  • California Public Employees Retirement System reported no remaining Carisma Therapeutics position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 12,568 Carisma Therapeutics shares in Q2 2021, an estimated $654K.
  • California Public Employees Retirement System first reported a position in Carisma Therapeutics in Q4 2020 and held it in 2 quarters.
  • California Public Employees Retirement System's Carisma Therapeutics position peaked at $654K in Q1 2021.
  • 105 funds tracked by Wall St. Rank held Carisma Therapeutics as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.